6,045 filings
Page 14 of 100
6-K
af2yb5
21 Nov 22
Director/pdmr Shareholding
11:55am
6-K
6uiserj e04z
15 Nov 22
Block Listing Interim Review
6:11am
3
61uvkzwad4z7kkdh1xs
14 Nov 22
Initial statement of insider ownership
5:05pm
SC 13D/A
lf0 w7p7ad09
14 Nov 22
Spero Therapeutics / GSK ownership change
5:02pm
6-K
in371ts7i
14 Nov 22
GSK Update: Zejula 2L In Us
6:27am
6-K
kpb7kx0b1qhusg 2yy
10 Nov 22
Sanofi-gsk Covid Booster Vaccine Approved by Eu
1:48pm
6-K
5j8bb
10 Nov 22
Director/pdmr Shareholding
11:06am
6-K
160fq
10 Nov 22
Block Listing Application
6:23am
6-K
8mwbtcmghsxlyn1kkrux
7 Nov 22
DREAMM-3 Phase III Trial for Blenrep
6:02am
3
1xx1ydorpj3s too
4 Nov 22
Initial statement of insider ownership
4:11pm
SC 13D
el1 mz7554
4 Nov 22
23andMe Holding / GSK ownership change
4:08pm
6-K
rh0617hl
3 Nov 22
Idmc Recommends Gepotidacin Early Efficacy Stop
6:55am
6-K
wup8e56rv19jkm2x3
2 Nov 22
3RD Quarter Results
12:13pm
6-K
hryfo11
2 Nov 22
GSK RSV Vaccine: Us Fda Priority Review
7:07am
6-K
kmnfkyb814d r5
1 Nov 22
Total Voting Rights
12:00pm
6-K
j162q5a
28 Oct 22
Ema Accepts GSK RSV Older Adult Vaccine for Review
7:31am
6-K
biurza4bs44
28 Oct 22
Ema Validates Maa for Cabotegravir La for Prep
7:26am
6-K
yydscqc
27 Oct 22
GSK Announces Fda Meeting Outcome on Daprodustat
8:47am
6-K
ympci3 d2gl7au
27 Oct 22
Contrast Phase III Programme for Otilimab Update
8:26am
6-K
ujj6wvm
25 Oct 22
Board Committee Changes
6:54am